On the morning of July 13, DHG Pharma held its Quarter 3 Company Meeting to review the business performance of the first six months of the year and encourage all employees to stay committed to achieving the targets for the remaining six months and the 2026 business goals.
Representing the Board of Management, Ms. Nguyen Ngoc Diep, Deputy General Director in charge of Production, shared the positive results achieved by DHG Pharma during the first six months of the year. Amid ongoing market challenges, these achievements reflect the unity, unwavering dedication, and determination of all DHG Pharma employees.
Speaking at the meeting, Mr. Toshifumi Kojima, General Director of DHG Pharma, emphasized that to achieve the 2026 goals, the Market Division must continue to play its leading role, with close collaboration and strong support from the Manufacturing and Office Divisions. He stressed that success can only be achieved through the unity and collective efforts of the entire DHG Pharma team.
The meeting concluded in an atmosphere of enthusiasm and determination, with all DHG Pharma employees ready to accelerate, break through challenges, and successfully accomplish the Company's 2026 business objectives.
An overview of DHG Pharma’s Quarter 3 Company Meeting at the Nguyen Van Cu Factory. This quarterly company meeting is one of DHG Pharma’s distinctive cultural traditions and has been maintained for many years as an integral part of the Company’s identity.
Ms. Nguyen Ngoc Diep, Deputy General Director in charge of Production, presented the business results for the first six months of the year and outlined the business strategy for the remaining six months.
The General Director delivered words of encouragement to all employees, calling on everyone to remain united, continue striving, and uphold a strong sense of responsibility in order to drive the Company’s sustainable growth and create long-term development opportunities for all employees.
DHG Pharma employees lined up neatly and attentively listened to the inspiring remarks from the Board of Management.
